EcoDrugPlus

Arginine Vasopressin Receptor 1b

Ensembl ID : ENSMMNG00015015940
Gene Symbol: AVPR1B
3 Cross references
134 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSMMNG00015012757
Gene Symbol: AVPR2
3 Cross references
231 Possible Orthologues:

Aromatase

Ensembl ID : ENSMMNG00015011743
Gene Symbol: LOC114903553
2 Cross references
306 Possible Orthologues:

Aromatase-Like

Ensembl ID : ENSMMNG00015011765
Gene Symbol: LOC114903554
2 Cross references
307 Possible Orthologues:

Aryl Hydrocarbon Receptor

Ensembl ID : ENSMMNG00015005766
Gene Symbol: AHR
3 Cross references
154 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSMMNG00015000130
Gene Symbol: AURKA
3 Cross references
233 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSMMNG00015020894
Gene Symbol: AURKB
2 Cross references
202 Possible Orthologues:

Aurora Kinase C

Ensembl ID : ENSMMNG00015000396
Gene Symbol: AURKC
3 Cross references
96 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSMMNG00015016617
Gene Symbol: BACE1
3 Cross references
217 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSMMNG00015016655
Gene Symbol: BDKRB1
1 Cross references
147 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSMMNG00015016639
Gene Symbol: BDKRB2
1 Cross references
356 Possible Orthologues:

Butyrylcholinesterase

Ensembl ID : ENSMMNG00015003992
Gene Symbol: BCHE
1 Cross references
130 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).